Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDBeam Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 5 | -$1.42 | -$0.94 | -$1.21 |
| Q2 2025 | 4 | -$2.40 | -$0.19 | -$1.23 |
| Q3 2025 | 4 | -$2.36 | -$0.18 | -$1.20 |
| Q4 2025 | 4 | -$2.32 | -$0.18 | -$1.18 |
| Q1 2026 | 3 | -$2.35 | -$0.18 | -$1.20 |
| Q2 2026 | 3 | -$2.39 | -$0.19 | -$1.22 |
| Q3 2026 | 3 | -$2.44 | -$0.19 | -$1.25 |
| Q4 2026 | 3 | -$2.45 | -$0.19 | -$1.25 |
Beam Therapeutics Inc. Earnings Date And Information
Beam Therapeutics Inc. last posted its earnings results on Tuesday, November 5th, 2024. The company reported $-1.17 earnings per share for the quarter, missing analysts' consensus estimates of $-1.13 by $0.04. The company had revenue of 14.27 M for the quarter and had revenue of 377.71 M for the year. Beam Therapeutics Inc. has generated $-2 earnings per share over the last year ($-1.72 diluted earnings per share) and currently has a price-to-earnings ratio of -14.11. Beam Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based on prior year's report dates.
Beam Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/05/2024 | Q3 2024 | -$1.13 | -$1.17 | -0.04 | $14.52 M | $14.27 M |
| 08/06/2024 | Q2 2024 | -$1.13 | -$1.11 | 0.02 | $14.18 M | $11.77 M |
| 03/29/2024 | Q1 2024 | -$1.21 | $7.41 M | |||
| 02/27/2024 | Q4 2023 | -$1.01 | $1.77 | 2.78 | $316.19 M | |
| 11/08/2023 | Q3 2023 | -$1.37 | -$1.22 | 0.15 | $17.09 M | $17.19 M |
| 08/08/2023 | Q2 2023 | -$1.38 | -$1.08 | 0.3 | $17.32 M | $20.12 M |
| 05/10/2023 | Q1 2023 | -$1.36 | -$1.16 | 0.2 | $24.21 M | |
| 02/28/2023 | Q4 2022 | -$1.32 | -$0.54 | 0.78 | $20.04 M | |
| 11/07/2022 | Q3 2022 | -$1.30 | -$1.56 | -0.26 | $7.15 M | $15.80 M |
| 08/09/2022 | Q2 2022 | -$1.08 | -$0.69 | 0.39 | $8.39 M | $16.65 M |
| 05/09/2022 | Q1 2022 | -$1.10 | -$0.80 | 0.3 | $8.43 M | |
| 02/28/2022 | Q4 2021 | -$1.02 | -$0.95 | 0.07 | $51.07 M | |
| 11/08/2021 | Q3 2021 | -$0.78 | -$0.42 | 0.36 | $1.07 M | $763,000 |
| 08/10/2021 | Q2 2021 | -$0.58 | -$1.23 | -0.65 | $8.34 M | $6,000 |
| 05/11/2021 | Q1 2021 | -$0.72 | -$3.35 | -2.63 | $6,000 | |
| 03/15/2021 | Q4 2020 | -$0.70 | -$1.59 | -0.89 | $6,000 | |
| 11/10/2020 | Q3 2020 | -$0.57 | -$0.69 | -0.12 | $1,500 | $6,000 |
| 08/12/2020 | Q2 2020 | -$0.56 | -$0.69 | -0.13 | $2,000 | $6,000 |
| 05/12/2020 | Q1 2020 | -$0.55 | -$0.99 | -0.44 | $6,000 | |
| 03/30/2020 | Q4 2019 | -$0.91 | $6,000 |
Beam Therapeutics Inc. Earnings: FAQ's
When is Beam Therapeutics Inc.'s earnings date?
Beam Therapeutics Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates.
How can I listen to Beam Therapeutics Inc.'s earnings conference
call?
The conference call for Beam Therapeutics Inc.'s latest earnings report can be listened to online.
How can I read Beam Therapeutics Inc.'s conference call transcript?
The conference call transcript for Beam Therapeutics Inc.'s latest earnings report can be read online.
How much revenue does Beam Therapeutics Inc. generate each year?
Beam Therapeutics Inc. (:BEAM) has a recorded annual revenue of $377.71 M.
How much profit does Beam Therapeutics Inc. generate each year?
Beam Therapeutics Inc. (:BEAM) has a recorded net income of $377.71 M. Beam Therapeutics Inc. has generated $-1.72 earnings per share over the last four quarters.
What is Beam Therapeutics Inc.'s price-to-earnings ratio?
Beam Therapeutics Inc. (:BEAM) has a price-to-earnings ratio of -14.11 and price/earnings-to-growth ratio is -4.99.